UTRN and Duchenne muscular dystrophy: Several proposed therapies to treat DMD involve expression of proteins that can substitute for dystrophin in its biochemical and biophysical functions at the sarcolemma, such as engineered miniaturized versions of dystrophin that contain a selection of critical functional domains (22) or a naturally occurring homologous protein, utrophin (23, 24).